CARIBOU BIOSCIENCES INC shareholders Q2 2022

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

CARIBOU BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 609,196$3,308,00010.93%
72 Investment Holdings, LLC 474,067$2,574,0003.98%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,378$254,692,0002.66%
PFM Health Sciences, LP 6,000,000$32,580,0001.24%
Velan Capital Investment Management LP 210,695$1,144,0001.16%
Avidity Partners Management LP 2,950,000$16,019,0000.37%
Green Alpha Advisors, LLC 252,272$1,370,0000.32%
Rokos Capital Management LLP 1,907,509$10,602,0000.31%
Franchise Capital Ltd 123,436$670,0000.22%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 181,304$984,0000.20%
Tekla Capital Management LLC 699,377$3,798,0000.15%
Nelson Capital Management, LLC 85,020$462,0000.13%
Duquesne Family Office 271,430$1,474,0000.11%
MAVERICK CAPITAL LTD 652,542$3,543,0000.09%
Granahan Investment Management 449,055$2,438,0000.08%
STANSBERRY ASSET MANAGEMENT, LLC 69,338$376,0000.08%
FARALLON CAPITAL MANAGEMENT LLC 2,203,895$11,967,0000.06%
Long Focus Capital Management, LLC 80,000$434,0000.04%
SHELTON CAPITAL MANAGEMENT 182,000$988,0000.04%
Virtus ETF Advisers LLC 20,215$110,0000.04%

This page lists CARIBOU BIOSCIENCES INC's shareholders in Q2 2022. To view CARIBOU BIOSCIENCES INC's shareholder history, click here.